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Purpose: To evaluate the diagnostic performance of gold nanorod (GNR)-enhanced 
optoacoustic imaging employing a conventional echographic device and to determine the most 
effective operative configuration in order to assure optoacoustic effectiveness, nanoparticle 
stability, and imaging procedure safety.
Methods: The most suitable laser parameters were experimentally determined in order to assure 
nanoparticle stability during the optoacoustic imaging procedures. The selected configuration 
was then applied to a novel tissue-mimicking phantom, in which GNR solutions covering a 
wide range of low concentrations (25–200 pM) and different sample volumes (50–200 µL) were 
exposed to pulsed laser irradiation. GNR-emitted optoacoustic signals were acquired either by a 
couple of single-element ultrasound probes or by an echographic transducer. Off-line analysis 
included: (a) quantitative evaluation of the relationships between GNR concentration, sample 
volume, phantom geometry, and amplitude of optoacoustic signals propagating along different 
directions; (b) echographic detection of “optoacoustic spots,” analyzing their intensity, spatial 
distribution, and clinical exploitability. MTT measurements performed on two different cell lines 
were also used to quantify biocompatibility of the synthesized GNRs in the adopted doses.
Results: Laser irradiation at 30 mJ/cm2 for 20 seconds resulted in the best compromise 
among the requirements of effectiveness, safety, and nanoparticle stability. Amplitude of 
GNR-emitted optoacoustic pulses was proportional to both sample volume and concentration 
along each considered propagation direction for all the tested boundary conditions, providing 
an experimental confirmation of isotropic optoacoustic emission. Average intensity of 
echographically detected spots showed similar behavior, emphasizing the presence of an “ideal” 
GNR concentration (100 pM) that optimized optoacoustic effectiveness. The tested GNRs also 
exhibited high biocompatibility over the entire considered concentration range.
Conclusion: An optimal configuration for GNR-enhanced optoacoustic imaging was 
experimentally determined, demonstrating in particular its feasibility with a conventional 
echographic device. The proposed approach can be easily extended to quantitative performance 
evaluation of different contrast agents for optoacoustic imaging.
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Introduction
Optoacoustic imaging, also known as photoacoustic imaging, is an emerging 
noninvasive and nonionizing imaging modality that combines high sensitivity and 
elevated contrast of optical imaging with spatial resolutions and penetration depths 
typical of ultrasound-based techniques.1–3 In fact, the penetration depth achievable 
with high-resolution optical imaging techniques is limited to a few millimeters, 
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while optical techniques using incoherent light extend the 
penetration depth to several centimeters but severely sacrifice 
spatial resolution.4–6 Optoacoustic imaging reaches a much 
more suitable compromise by exploiting the photoacoustic 
effect,7 achieving increased penetration depths with respect 
to pure optical methods and improved tissue differentiation 
with respect to conventional acoustic techniques.8
Thanks to the significant optical absorption of hemoglobin, 
optoacoustic imaging has already been applied to in vivo 
visualization of human vessel networks (eg, breast tumor 
microvasculature,9,10 forearm vasculature11). However, 
in order to extend the potential of this new technique to 
molecular imaging applications, several research groups are 
currently working to exploit the unique optical properties 
of noble metal nanoparticles (NPs), whose surface plasmon 
resonance results in a strong absorption of the incident 
laser energy, with the subsequent generation of detectable 
ultrasound (US) waves.8,12
Numerous plasmonic NPs have been recently developed 
and tested as potential contrast agents (CAs) for optoacoustic 
imaging.3,13–16 In most cases gold is the metal of choice, due to 
its high stability, facile chemistry, and easy bioconjugation,12,17 
as well as its generally benign toxicity profile.15,18–21 Therefore, 
various types of gold NPs have been experimentally tested as 
optoacoustic CAs, such as nanospheres,4 nanoshells,22 hollow 
nanospheres,14 nanobeacons,3 and nanocages,23 but the class 
of NPs most significantly explored for optoacoustic imaging 
applications is represented by gold nanorods (GNRs),8,15,24–28 
which are also attracting increasing interest because of 
their exceptional ability to accumulate in tumors29 and their 
potential for simultaneous photothermal therapy.30,31
Nevertheless, important issues related to the application 
of GNR-enhanced optoacoustic imaging still hinder its 
translation into clinical routine. Major concerns are related 
to: (1) laser-induced degradation of GNRs during the imaging 
procedure, which is accompanied by drastic changes in both 
the toxicity profile and the optical-absorption spectrum of 
irradiated NPs,32–34 thus potentially affecting both imaging 
safety and effectiveness; (2) potential pitfalls due to 
anisotropic propagation of optoacoustic signals, which makes 
the investigation of possible preferential directions in GNR-
emitted signals a crucial issue for determining the optimal 
relative placement of laser and US devices during diagnostic 
procedures; and (3) lack of experimental data quantifying 
the sensitivity of commercial echographic devices to small-
volume variations of low-concentration GNRs, whose 
determination represents a sine qua non condition for 
future applications of this method for therapeutic treatment 
monitoring and patient follow-up.24 On the contrary, most 
recent papers on optoacoustic imaging development10,15,24,26,28 
are still based on the employment of dedicated US systems 
requiring time-consuming scanning procedures and image 
reconstruction algorithms, which actually constitute a further 
obstacle for a successful clinical translation.
In this study, we investigated all these aspects in a novel 
experimental setup containing a custom-designed tissue-
mimicking phantom that allowed us to study the effects 
of all the main parameters influencing the optoacoustic 
performance of GNRs. The following specific aims were 
addressed: (1) determination of GNR degradation during the 
imaging procedure as a function of both laser fluence and 
exposure duration; (2) assessment of possible anisotropies 
in optoacoustic signal propagation for different sets of 
experimental conditions; and (3) quantification of the 
optoacoustic contrast enhancement produced by GNRs in 
low concentrations and variable sample volumes on images 
acquired with a conventional echographic device.
Finally, since recent literature has documented that 
cytotoxicity of gold NPs can follow complex size-dependent 
patterns,35–38 being also variable between different cell 
types,36,39–41 we quantified the biocompatibility of our 
employed GNRs through MTT (3-[4,5-dimethythiazol-2-yl]-
2,5-diphenyl tetrazolium bromide) assays performed on two 
different cell lines.
Materials and methods
Materials
Hexadecyltrimethylammoniumbromide (CTAB), ben-
zyldimethylammoniumchloride hydrate (BDAC), gold(III) 
chloride trihydrate (HAuCl
4
), sodium borohydride 
(NaBH
4
), silver nitrate (AgNO
3
), l-ascorbic acid, and 
MTT were purchased from Sigma-Aldrich (Milan, Italy). 
HS-PEG3000-OH was purchased from Rapp Polymere 
 (Tuebingen, Germany). Fetal bovine serum, Dulbecco’s 
modif ied Eagle’s medium, l-glutamine, penicillin-
 streptomycin, phosphate-buffered saline, trypsin, and dime-
thyl sulfoxide were purchased from Euroclone (Milan, Italy). 
All chemicals were used as received. Ultrapure-grade 
water with a conductivity of 18.2 MΩ was used in all the 
experiments.
Synthesis of GNRs
GNRs were synthesized through a procedure based on the 
seeded-growth method.42 Spherical Au seeds were prepared 
first by chemical reduction of HAuCl
4
, followed by their 
anisotropic growth by using a binary surfactant mixture 
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composed of BDAC and CTAB, which allows for obtaining 
NRs with an aspect ratio higher than 4.542 (where the “aspect 
ratio” represents the ratio of the major axis length to that of 
the minor axis). By controlling the relative concentrations 
of the gold seeds and of the growth solution, it was  possible 
to obtain GNRs absorbing in the near-infrared (NIR) 
spectral region.
In detail, 0.5 mL of an aqueous solution of 0.2 M of 
CTAB was added to 0.5 mL of a 0.5-mM aqueous solution 
of HAuCl
4
, obtaining a light-yellow solution. Then, 60 µL 
of a 0.01-M NaBH
4
 solution, prepared using ice-cold water, 
was added. The solution was mixed and kept in a water bath 
at 30°C for 1 hour before use. A binary surfactant mixture 
of BDAC and CTAB was then used to grow NRs with a 
maximum plasmon band around 1100 nm. The mixture was 
prepared by sonicating 0.05 g (1.3 × 10–4 mol) of CTAB 
in 5 mL of 0.15 M BDAC for 20 minutes at 40°C. At this 
point, the Au precursor solution (5 mL of a 1-mM aqueous 
HAuCl
4
 solution) was added, and after gentle mixing, 200 µL 
of 4 mM AgNO
3
 was added. Finally, ascorbic acid (70 µL 
of 0.0778 M ascorbic acid in water) was used as reducing 
agent. The growth was carried out for 2 hours after addition 
of 12 µL of the seed solution prepared, as described before. 
The NRs were purified through controlled precipitation by 
centrifugation (8600 g, 30 minutes), removal of the solvent, 
and redispersion in freshwater. This purification step was 
repeated three times.
In order to increase the biocompatibility of the 
 nanorods, a ligand-exchange procedure was carried out. 
An excess of  thiolated polyethylene glycol (PEG) ligand 
 (HS-PEG3000-OH, 200 mg) was added to a solution of 
GNRs in water (1.5 mL, 5 nM), and the mixture left to 
react overnight. The NRs were purified through controlled 
 precipitation by centrifugation (8600 g, 30 minutes), removal 
of the solvent, and redispersion in freshwater. This purifica-
tion step was repeated three times, yielding the final PEG-
coated GNRs used in the following experiments.
It is important to observe that the PEG molecule employed 
binds to the surface of the nanocrystals by forming a stable 
covalent bond between the thiol group and the gold atoms, 
while exposing the terminal hydroxyl groups (–OH) to the 
environment. These highly biocompatible ligands replace 
the CTAB molecules originally covering the surface of the 
as-synthesized NRs, which instead are known to be highly 
toxic.43,44 Successful PEGylation of GNRs was verified 
through zeta-potential measurements of the GNRs in water 
before and after the ligand-exchange procedure, as described 
in the next section.
Physicochemical characterization  
of GNRs
Transmission electron microscopy and absorption 
spectroscopy
Size and morphology of the PEG-coated GNRs were 
evaluated by transmission electron microscopy (TEM) 
using a Jeol Jem 1011 microscope operated at 100 kV. The 
sample was prepared by placing a few drops of colloidal gold 
solution of nanocrystals onto carbon-coated copper grids and 
evaporating it at room temperature in a fume hood.
Optical-absorption measurements of the samples were 
carried out using a Cary 5000 ultraviolet visible (UV-vis) 
NIR spectrophotometer (Varian, Palo Alto, CA). All 
measurements were performed at room temperature on 
solutions of GNRs dispersed in water in quartz cuvettes with 
a 1-cm path length.
Dynamic light-scattering and zeta-potential 
measurements
A Zetasizer Nano ZS90 (Malvern, PA, USA) equipped with 
a 4.0-mW He–Ne laser operating at 633 nm and an avalanche 
photodiode detector was used to measure the size distribution 
of the GNRs obtained and to verify the effectiveness of the 
PEGylation procedure. Measurements were made at 25°C 
in aqueous solutions (pH 7) of the particles. The values 
were determined using the Smoluchowsky approximation 
(f[ka] = 1.5), and they were estimated as the average of 
20 repeated measurements.
In particular, during size-distribution measurements, the 
He–Ne laser was used to provide a light source to illuminate 
the sample particles in solution within the instrument cell, 
while the avalanche photodiode detector was used to measure 
the intensity of the corresponding scattered light. Once the 
detector measured the scattered light, this was converted to 
the size of the particles. Finally, the computer elaborated a 
graph representing the size distribution of the particles in 
solution.
Elemental analysis
The concentration of the GNR stock solution was determined 
by elemental analysis, carried out by inductively coupled 
plasma atomic emission spectroscopy (ICP-AES) with a 
Varian Vista AX spectrometer by measuring the Au content 
of the purified samples. Samples were dissolved overnight 
in 1 mL of concentrated HCl/HNO
3
 (3:1, volume/volume), 
diluted to 5 mL with ultrapure water, and the resulting 
solution was analyzed directly.
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Preliminary degradation tests on gold 
nanorods
Before testing the optoacoustic behavior of the GNRs, we 
investigated their stability under laser irradiation, in order 
to determine the most suitable parameter configuration to be 
adopted in the subsequent optoacoustic experiments.
Preliminary irradiation tests with an Nd:YAG pulsed laser 
(Spectra-Physics Quanta-Ray GCR-190-10; Newport, Moun-
tain View, CA) emitting at a wavelength of 1064 nm were per-
formed by directing 10-ns pulses from the top into an open vial 
containing 250 µL of a 40-pM GNR solution. The laser-beam 
area was expanded using a homebuilt beam expander and was 
carefully aligned to the center of the vial, in order to illuminate 
the solution uniformly and at the same time to avoid irradiation 
of the wall. The energy levels of laser pulses were adjusted by 
directly varying the flashlamp-discharge voltage.
GNR stability was studied as a function of both laser 
 fluence and exposure duration. Seven samples were tested at a 
repetition rate of 10 Hz: the laser beam irradiated the sample 
for either 20 seconds (samples 1–3) or 40 seconds (samples 
4–6) employing a constant laser fluence (30 mJ/cm2 for 
samples 1 and 4, 60 mJ/cm2 for samples 2 and 5, 90 mJ/cm2 
for samples 3 and 6), then the laser beam was interrupted 
through a shutter. Furthermore, GNR degradation after 
consecutive exposure to three different and progressively 
increasing laser fluences (30, 60, and 90 mJ/cm2; 20-second 
exposure for each fluence) was also checked (sample 7). Each 
sample was analyzed in triplicate.
Taking into account the fact that the employed laser-
beam area was about 0.5 cm2, the energy delivered by single 
laser pulses to the GNR solution at each of three considered 
laser fluences was 15 mJ, 30 mJ, and 45 mJ, respectively. 
Therefore, given the constant pulse-repetition rate (10 Hz), 
each second of pulsed irradion on GNRs was equivalent 
to 1 second of continuous wave irradiation at a power of 
150 mW, 300 mW, and 450 mW, respectively. GNR changes 
in optical properties and morphology were monitored by 
UV-vis-NIR spectroscopy and TEM analysis, respectively.
Optoacoustic experiments
Phantom construction
The phantom employed for the optoacoustic experiments of 
this study consisted of a tissue-mimicking hydrogel block45–47 
equipped with shaped housings for GNR sample solutions 
and contained in a polymeric box, specifically designed to 
allow the acquisition of GNR-emitted photoacoustic waves 
through different US probes in various configurations.
The box (8 × 7 × 4 cm) was fabricated by means of 
stereolithography,48–52 a technique that has also been recently 
used by our research group for highly accurate phantom 
reproductions of human organs.53 Details of the phantom box 
adopted in this study are illustrated in Figure 1A and B.
Longitudinal
probe hole
Lateral probe hole Flat wing for phantom
positioning
Solution housing Hydrogel Silicon connector
Echographic
transducer hole
A B
C D E
Figure 1 Computer-aided design model of the phantom box (A and B) and corresponding pictures of the employed tissue-mimicking phantom (C–E). (A) Global 3-D view 
of the box; (B) main cross section of the box; (C) phantom top view; (D) phantom lateral view; (E) phantom bottom view. 
Note: Main phantom parts are indicated in the figure (see the text for further details).
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The holes at the bottom of the box fitted the dimensions 
of either a single-element US probe (circular holes, 16 mm 
in diameter) or a linear echographic transducer (rectangular 
holes, 55 × 12 mm) and each of them was aligned with 
a corresponding solution housing in the hydrogel, in 
order to receive the photoacoustic waves generated in the 
“longitudinal” direction. The additional circular holes placed 
in the lateral walls of the box, and in turn aligned with two 
solution housings, allowed the use of further single-element 
probes to acquire the signals emitted in the “lateral” direction. 
The two flat wings on the box’s lateral walls were designed 
to facilitate the stable phantom positioning on a specific 
supporting device.
The tissue-mimicking hydrogel was synthesized by 
cross-linking a water solution of carboxymethyl cellulose 
sodium salt and hydroxyethyl cellulose, using divinylsulfone 
as a cross-linking agent.45–47 After the mixing stage, an 
alkaline water solution of potassium hydroxide was added 
as a catalyst, and the resulting solution was poured into the 
phantom box, according to the following procedure. Before 
filling, the top of the box was sealed by means of a silicon 
layer, fabricated using a proper resin mold in turn realized by 
means of stereolithography, which presented four precisely 
positioned and shaped “bumps” (aimed at creating the 
corresponding solution housings directly into the hydrogel 
mass) and two circular stoppers (to close the lateral holes 
of the box). The box was then placed upside down on a flat 
surface and the hydrogel solution was poured through one of 
the bottom holes, being careful to avoid bubble formation. 
After 12 hours at room temperature, a complete hydrogel 
cross-link occurred: it was possible to remove the silicon 
layer, and the phantom was ready for use.
Figure 1C–E shows the finally obtained phantom, also 
equipped with a custom-designed silicon connector sealed 
on the bottom in order to ensure the proper alignment of 
echographic transducers with the corresponding holes. Two 
different versions of the phantom were prepared, differing in 
the shape of the 6-mm-deep solution housings, which were 
manufactured with either a square base (7 × 7 mm, which 
is the case shown in Figure 1C) or a circular one (6 mm 
in radius).
Experimental acquisitions with single-element 
ultrasound probes
Figure 2 schematically illustrates the experimental setup 
realized for the acquisition of GNR-emitted photoacoustic 
waves through single-element US probes.
Laser irradiation of GNR solutions was obtained through 
the Nd:YAG laser, lasing 1064-nm 10-ns pulses at a pulse-
repetition rate of 10 Hz. By employing apposite high-power 
dielectric mirrors and an iris, the laser beam was directed 
to illuminate just the phantom housing containing the GNR 
solution under testing. Two single-element unfocused US 
probes, both having a center frequency of 1 MHz and a 
diameter of 16 mm (V-303-SU; Panametrics, Waltham, 
MA), were inserted in the corresponding phantom box 
holes (coupled to the tissue-mimicking hydrogel by means 
of US coupling gel), in order to receive the photoacoustic 
signals along both the “longitudinal” and the “lateral” 
directions. Laser fluence was ∼30 mJ/cm2 (ie, about 30% of 
the maximum permissible exposure for the skin at a laser 
wavelength in the NIR spectral range54), and incidence angle 
of the laser beam was about 70°, in order to avoid direct 
interaction between the laser beam and the US probe surface. 
Laser
beam
Nd-YAG
pulsed laser
(1064 nm)
Tissue-mimicking
hydrogel phantom
GNR solution
housing
High-power
dielectric mirrors
Lateral
US probe
Iris
Longitudinal
US probe
Figure 2 Scheme of the experimental setup adopted for studying the optoacoustic behavior of gold nanorods (GNRs). 
Note: Main setup characteristics are indicated in the figure (see the text for further details). 
Abbreviation: US, ultrasound.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
4377
Gold nanorods for optoacoustic molecular imaging
International Journal of Nanomedicine 2012:7
The acoustic waveforms received were 10-dB amplified by 
two US receivers (5077PR and 5073PR; Panametrics), then 
recorded at a sampling rate of 100 MHz (14 bits) by a data-
acquisition board (PCI-5122; National Instruments, Austin, 
TX) synchronized to the laser and stored on a computer for 
off-line analysis. Signal acquisition and data transfer were 
controlled using LabVIEW (National Instruments).
Effectiveness of aqueous solutions of GNRs in generating 
detectable photoacoustic signals was evaluated by irradiating 
for 20 seconds either samples of constant volume (100 µL) 
containing variable GNR concentrations (from 25 to 200 pM, 
corresponding to the range 1.5 × 1010–1.2 × 1011 GNRs/mL) 
or samples of different volumes (range 50–200 µL) at a fixed 
concentration (100 pM, 6 × 1010 GNRs/mL). Pure water was 
also irradiated in the same conditions and considered as a 
control for confirming that US signals detected when irradi-
ating the samples were caused by GNRs and not by the pure 
solvent. For each considered combination of sample volume 
and concentration, three different solutions were prepared 
and separately irradiated within the described setup (results 
reported in the next section represent the corresponding 
average values).
Experimental acquisitions with echographic 
transducer
In order to assess the potential exploitability of GNR-emitted 
photoacoustic signals in a clinical context, the experiments 
described in the previous paragraph were repeated employing 
the same phantom (in the version with squared solution hous-
ings) and the same laser settings combined with a different 
US acquisition system.
The GNR solutions to be tested were deposited in 
the phantom housings aligned with the box’s rectangular 
holes, in which a linear echographic transducer (LA532; 
Esaote, Florence, Italy) was inserted and coupled to the 
phantom matrix by means of coupling gel. The transducer 
was linked to a conventional clinically available digital 
echograph (Megas GPX; Esaote Spa), in turn connected 
via optic fiber to a prototype platform for acquisition of 
unprocessed radio-frequency (RF) data (Femmina, ElEn, 
Florence, Italy).
The transducer was employed in “receiving-only” mode 
(ie, it did not emit any US signal), and 200 frames of RF data 
were acquired during each 20-second solution irradiation 
and stored in the Femmina hard disk for off-line analysis. 
A conventional echographic image was also acquired before 
each laser irradiation, in order to verify the proper transducer 
positioning and its reproducibility.
Optoacoustic data analysis
Off-line analysis of acquired signals and images was conducted 
employing different software tools and custom-implemented 
algorithms, depending on the specific experimental setup 
employed for the corresponding acquisition, as detailed in 
the following sections.
Single-element probe data
US signals received by single-element probes were processed 
through LabVIEW algorithms specifically implemented for 
the purposes of this study.
For each irradiated solution, a sequence of 200 signals 
was acquired by each employed probe. In the first step of off-
line analysis, all the signals were band-pass–filtered in order 
to cancel noise contribution external to the probe frequency 
band (0.3–1.8 MHz). Taking into account the sound-
propagation velocity in the employed tissue-mimicking 
material (1560 m/second46), the phantom geometry and 
the time instants of synchronized laser pulse emission, a 
6-µs rectangular window was then used to select on each 
signal the portion containing the waveform to be analyzed 
(corresponding to the photoacoustic pulse emitted by the 
considered solution as a consequence of laser irradiation). In 
the next analysis step, the absolute value |V(t)| was computed 
for each windowed signal V(t) and the corresponding mean 
value |V(t)|
m
 was calculated using the following formula:
 V t
T
V t dt
m
T( ) = ( )∫1 0  (1)
where T = 6 µs. The values of |V(t)|
m
 were averaged over the 
corresponding sequence of acquired signals and the result 
was labeled as ,|V(t)|
m
..
The same analysis was conducted on the signals acquired 
during pure-water irradiation, and the resulting average 
value was subtracted from the ,|V(t)|
m
. value of each 
considered sequence, identifying the finally obtained value 
,|V(t)|
m
.
eff
 as the “optoacoustic signal amplitude” associated 
with the corresponding combination of GNR concentration, 
sample volume and acquisition direction:
 < ( ) > = < ( ) > − < ( ) >V t V t V t
m eff m GNRs m water
 (2)
The values of photoacoustic signal amplitude were sepa-
rately plotted as a function of GNR concentration and sample 
volume for both the considered acquisition directions.
In order to further emphasize the specific variation of 
photoacoustic signal amplitude produced by each adopted 
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increment in GNR concentration, for each considered con-
centration level, we also computed the rate of enhancement 
(RoE) with respect to the preceding lower concentration 
level, according to the following formula:
 RoE b
V t b V t a
V t a
m m
m
( ) = < ( ) > ( )− < ( ) > ( )
< ( ) > ( )  (3)
where a and b refer to two consecutive levels of GNR 
concentration.
Echographic transducer data
Each RF data frame acquired by the echographic trans-
ducer was composed of 178 echographic tracks with 
4600 points/track. The occurrence of optoacoustic pulses 
could be detected as the appearance of hyperintense 
clusters of pixels, called “spots,” over a completely black 
background.
A custom-developed algorithm was implemented using 
the Fortezza software in order to detect automatically the 
presence of spots in each acquired image frame and to 
measure the corresponding intensity (that was identified as 
the maximum value among the intensities of single pixels 
belonging to the considered spot). The intensity of the 
optoacoustic signal associated with each tested combination 
of GNR concentration, and sample volume was calculated 
as the average intensity of the spots detected in the 
corresponding frame sequence divided by the average of the 
maximum intensities measured in each frame of a sequence 
acquired during pure-water irradiation.
We also studied the spatial distribution of spot intensity 
within the solution housing: in each frame acquired at a 
given GNR concentration, the area corresponding to the 
solution housing was divided into seven 1-mm-wide regions 
of interest, and the average intensity of the spots occurring 
in each region of interest was plotted as a function of lateral 
distance from the solution housing center.
Biocompatibility tests
The actual biocompatibility of our GNRs was directly and 
specifically quantified through MTT assays performed on two 
different cell lines, as detailed in the following sections.
Cell culture and treatment with GNRs
Human epithelial adenocarcinoma cell line (HeLa) and 
human breast cancer cell line MCF-7 were maintained in 
Dulbecco’s modified Eagle’s medium supplemented with 
10% fetal bovine serum, 2 mM l-glutamine and penicillin-
streptomycin (5 mg/mL). Cells were grown at 37°C in a 95% 
humidified, 5% CO
2
 atmosphere.
HeLa and MCF-7 cells were plated into 96-well plates at 
a density of 2.0 × 104 cells/mL in 100 µL of culture medium. 
After a 12-hour incubation, the medium was removed from 
each well and replaced with 100 µL of fresh GNR suspension 
at variable concentration (50, 100, and 200 pM) prepared in 
complete medium. Cells were further incubated for 24, 48, 
and 72 hours with GNRs before the MTT viability assay 
was performed. In each experiment, H
2
O
2
 (20 mM) was used 
as a cell death–positive control, while cells not exposed to 
particles served as negative controls.
MTT assay
The MTT viability assay was performed to estimate the cyto-
toxicity of the GNRs to the two considered cell lines. At least 
three independent experiments were conducted for each cell 
line, and six replicate wells were employed for each tested 
GNR concentration in each independent experiment.
After 24, 48, and 72 hours of GNR exposure, the medium 
was removed, the cells were washed with phosphate-buffered 
saline, and a solution containing 0.5 mg/mL of MTT dissolved 
in culture medium was added to each well. After 3 hours’ 
incubation at 37°C, the MTT, reduced by the mitochondrial 
reductase of vital cells, formed a dark insoluble product – 
 formazan. At this point, the medium was removed and the dark 
pellet was dissolved in dimethyl sulfoxide, leading to a violet 
solution whose absorbance at 570 nm was measured with 
Epoch Multi-Volume Spectrophotometer System (BioTek, 
Winooski, VT). The viability percentage was expressed as 
the relative growth rate (RGR) by the equation:
 RGR D Dsample control= ( ) ⋅ 100% (4)
where D
sample
 and D
control
 are the absorbances of the considered 
sample and the negative control, respectively.
All the described cytotoxicity assays were performed 
according to the protocol described in the ISO 10993-5 
international guide.55
Statistical analysis was carried out using Student’s t-test; 
differences were considered statistically significant when 
P-value was less than 0.01.
Results
GNR physicochemical characterization
The synthesized GNRs presented a length of 55 ± 5 nm 
and a diameter of 8 ± 1 nm, with a resulting aspect ratio of 
about 6.9, as observed by TEM microscopy (Figure 3A). 
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UV-vis-NIR spectroscopic analysis showed that as expected, 
the nanocrystals presented two peaks in their absorp-
tion  spectrum, corresponding to the transverse and the 
longitudinal plasmon resonance bands, centered at 525 nm 
and 1057 nm, respectively (Figure 3B).
Successful PEGylation of the GNRs was confirmed by 
zeta-potential measurements of the NPs in water before and 
after the ligand-exchange procedure. As expected, the as-
synthesized GNRs showed a positive zeta-potential value 
(+38.0 ± 0.8 mV) because of the quaternary amine of the 
CTAB surfactants; on the other hand, PEG-coated GNRs 
showed an almost neutral surface charge (−2.0 ± 0.4 mV), 
in accordance with results available in the literature.35,56
Dynamic light-scattering analysis showed that the GNRs 
were highly monodispersed, with an average hydrodynamic 
diameter in water of 62 ± 6 nm.
The concentration of atomic gold in the stock solution 
was determined to be 4 nM by ICP-AES. The average volume 
of a single GNR calculated through TEM analysis yielded a 
GNR density of approximately 2.4 × 1012 GNRs/mL.
Laser irradiation effects and parameter 
selection
Stability under laser irradiation was evaluated as a 
function of either laser fluence and exposure duration 
through UV-vis-NIR spectroscopy and TEM analysis. 
Figure 4 summarizes the average normalized data derived 
from the UV-vis-NIR spectra of aqueous solutions of GNRs 
acquired after each irradiation performed.
Exposure of the nanocrystals to the laser for 20 seconds 
decreased their longitudinal absorption peak almost linearly 
with increasing laser fluences (see Figure 4, full triangles), 
with the minimum tested value (30 mJ/cm2) providing a 
 normalized optical density very close to that of the starting 
GNR (reduction , 10%). A similar degradation trend, 
although slightly more pronounced, was observed when the 
samples were exposed to each laser fluence for 40 seconds 
(see Figure 4, empty triangles), while the consecutive 
irradiation of the same sample with the three increasing 
laser fluences led to a marked reduction in the longitudinal 
absorption peak to less than 60% of its initial value (see 
Figure 4, empty circle).
The corresponding morphological changes were inves-
tigated by TEM analysis: Figure 5 shows TEM images of 
the GNRs irradiated with different combinations of laser 
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Figure 3 (A and B) Characterization of the polyethylene glycol–coated gold nanorods. (A) Transmission electron microscopy image (scale bar is 100 nm); (B) ultraviolet-
visible near-infrared absorption spectrum.
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Figure 4 Normalized optical densities of gold nanorods (GNRs) at 1064 nm after 
exposure to laser fluences of 30, 60, and 90 mJ/cm2 for 20 seconds (black triangles) 
and 40 seconds (white triangles), and consecutively to the three different laser 
fluences for 20 seconds each time (white circle).
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fluence and exposure duration. The harshest adopted laser 
parameters led to the transformation of most GNRs into 
nearly spherical particles with diameters ranging from 10 to 
20 nm, although smaller and bigger particles could be also 
found, while the progressively milder conditions showed an 
increasing percentage of GNRs that were not modified by 
laser irradiation.
In summary, the GNRs showed an almost linear degra-
dation pattern with increasing laser fluence. However, the 
smoothest conditions used in these experiments (30 mJ/cm2 
irradiation for 20 seconds) caused only a negligible GNR 
degradation, yielding an absorption spectrum very similar 
to the starting one. This laser configuration was selected for 
the subsequent optoacoustic experiments.
Optoacoustic behavior of GNRs
The selected laser-exposure configuration was employed in 
combination with the experimental setup shown in Figure 2 
to determine the effect of GNR concentration and sample 
volume on the amplitude of the corresponding optoacoustic 
signals.
Laser irradiation of a constant volume of GNR solution 
(100 µL) produced optoacoustic amplitudes that increased 
proportionally with GNR concentration along both the considered 
propagation directions, and for each tested concentration 
(range 25–200 pM, 1.5 × 1010−1.2 × 1011 GNRs/mL), the 
higher signal amplitude was found in the longitudinal 
direction (Figure 6A). Similar trends were also observed 
when GNR concentration was kept constant to a 
fixed value (100 pM, 6 × 1010 GNRs/mL) and samples of 
variable volume (50–200 µL) were exposed to the laser 
(Figure 6B).
In order to better characterize the effect of GNR 
concentration on the amplitude of optoacoustic signals emitted 
along both the considered directions, we used Equation 3 to 
calculate the RoE produced in optoacoustic signal amplitude 
by each specific increment in GNR concentration with respect 
to the preceding lower concentration level.
Two important aspects can be evidenced from the 
obtained results, reported in Figure 7: (1) in the whole 
GNR concentration interval studied, the optoacoustic 
enhancements on the two considered directions followed very 
similar patterns: this represents a confirmation of the isotropic 
generation of photoacoustic signals by GNRs, because the 
same concentration increment simultaneously produces two 
analogous RoE values along two orthogonal directions; and 
(2) in the range 50–200 pM (3 × 1010−1.2 × 1011 GNRs/mL), a 
significant enhancement of the optoacoustic amplitude occurs 
each time the concentration is doubled (enhancement is in the 
order of 80% for a doubling from 50 to 100 pM and in the 
order of 170% for a doubling from 100 to 200 pM).
The implications of the observed trends of optoacoustic 
signal amplitude for clinical employment of photoacoustic 
imaging will be discussed in detail in the Discussion 
section.
Detection of GNR-emitted optoacoustic 
signals with a conventional echographic 
device
Results presented in the previous paragraph were derived 
from the employment of experimental single-element US 
probes combined with data-analysis algorithms based on 
the application of Equations 1, 2, and 3. These techniques 
facilitate gaining insight into the intrinsic properties of 
acquired signals and in the underlying physical phenomena; 
however, in order to effectively discuss a potentially rapid 
translation of the developed methods into clinical practice, it 
is mandatory to verify their actual exploitability in the pres-
ence of clinically available imaging devices based on more 
conventional algorithms.
Therefore, the most interesting experiments performed 
with single-element US probes (ie, 20-second laser 
irradiations at 30 mJ/cm2 of GNR solutions of variable 
concentration and volume) were repeated employing a 
conventional clinically available echographic device.
Results reported in Table 1 showed that normalized 
intensity of echographically detected optoacoustic spots 
confirmed the proportionality to GNR concentration in 
Figure 5 Transmission electron microscopy images of the gold nanorods after 
different laser exposures: (A) 30 mJ/cm2 for 20 seconds; (B) 60 mJ/cm2 for 
40 seconds; (C) 90 mJ/cm2 for 40 seconds; (D) 30, 60, and 90 mJ/cm2 consecutively, 
for 20 seconds each time. 
Note: Scale bars are 200 nm.
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the considered range, also highlighting the presence of a 
sort of “optimal concentration” at about 100 pM (6 × 1010 
GNRs/mL): concentrations in the range 0–50 pM produced 
spots whose average intensity was less than 10% higher 
than  maximum intensities registered during pure-water 
irradiation, while a 100-pM GNR solution produced an 
enhancement of more than 60% with respect to maximum 
water intensity, and this value was only slightly increased 
by a further concentration increment to 200 pM (1.2 × 1011 
GNRs/mL).
Nevertheless, as shown in Table 2, the average spot-
intensity enhancement produced by laser irradiation of 
100 µL of a 100-pM GNR solution was mostly saved even 
when sample volume was reduced to 50 µL (average spot 
intensity decreased by only 14%), while it was significantly 
amplified in the case of a doubling in sample volume (200 µL 
of 100 pM GNR solution produced an average spot intensity 
almost double with respect to the 100-µL case).
In order to characterize further the potential of GNRs as 
contrast agents for optoacoustic imaging, for each considered 
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Figure 6 (A and B) Optoacoustic signal amplitude as a function of acquisition direction. (A) Effect of gold nanorod (GNR) concentration (fixed sample volume: 100 µL); 
(B) effect of GNR sample volume (fixed sample concentration: 100 pM = 6 × 1010 part/mL). 
Notes: The schematic sketches beside each curve represent the solution housing “seen” by the corresponding ultrasound probe in the considered experimental conditions 
(see Discussion for details). Error bars represent standard deviations.
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concentration level, we studied the spatial distribution of 
spot intensities within the solution housing by plotting the 
average spot intensity as a function of lateral distance from 
the housing center. The graph is shown in Figure 8, visually 
confirming the presence of the previously identified  “optimal 
concentration” and showing that for all the considered 
GNR concentrations, spot-intensity distribution presented 
a characteristic bell-like shape whose subtended area was 
proportional to the GNR concentration level.
Biocompatibility of GNRs
Figure 9 summarizes the results obtained on cytotoxicity of 
our synthesized GNRs studied with human cell models (HeLa 
and MCF-7) through MTT tests performed at different time 
intervals (24, 48, and 72 hours) for the previously considered 
concentrations (50, 100, and 200 pM), according to protocols 
described in ISO 10993–5.55
After 24-hour incubation (Figure 9A), cell viability as a 
function of GNR concentration was almost constant for MCF-7 
and showed a slight (not statistically significant) decrement 
for HeLa. After 48 hours (Figure 9B), the cell-viability pat-
tern did not change for MCF-7, while HeLa showed a 25% 
reduction in cell viability in correspondence with 200 pM 
GNR concentration (P , 0.01). After 72-hour incubation 
(Figure 9C), MCF-7 also showed a cell-viability reduction (9%) 
at the highest considered GNR concentration, while the behav-
ior of HeLa cells was the same as that shown at 48 hours.
Therefore, exposure to GNRs in concentrations up to 
200 pM for 72 hours never caused significant decrements 
in MCF-7 cell viability; in the case of HeLa cells, a statisti-
cally significant viability reduction was observed only after a 
72-hour incubation with a 200-pM GNR solution, indicating 
that HeLa cells are more sensitive to GNR exposure than 
MCF-7. However, in all the considered cases, cell viability 
was maintained well above 70% (minimum observed values 
were 91% for MCF-7 and 75% for HeLa, and these values 
rose to 99% and 93% respectively, when the suggested opti-
mal concentration of 100 pM was employed). Consequently, 
according to the ISO 10993-5 international guide,55 which 
classifies as a cytotoxic effect a reduction in cell viability by 
more than 30%, we can state that our synthesized GNRs, at 
least in the dosages adopted, have high biocompatibility since 
they did not cause cytotoxic effects in the cell lines studied.
Discussion
Stability of GNRs under laser irradiation
Experimental results reported in the previous section 
confirmed and extended the previously reported evidence 
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Figure 8 Normalized average spot intensity as a function of lateral distance from 
the solution housing center for each considered gold nanorod concentration.
Table 1 Normalized spot intensity as a function of gold nanorod 
(GNR) concentration (sample volume = 100 µL)
GNR concentration Normalized spot intensity
pM 1010 part/mL
0 0 1.00 ± 0.01
25 1.5 1.05 ± 0.04
50 3.0 1.09 ± 0.03
100 6.0 1.63 ± 0.11
200 12.0 1.80 ± 0.09
Table 2 Normalized spot intensity as a function of gold nanorod 
(GNR) sample volume (GNR concentration = 100 pM)
GNR sample volume 
(μL)
Normalized spot intensity
50 1.40 ± 0.09
100 1.63 ± 0.11
200 2.99 ± 0.15
100 µL of pure water 1.00 ± 0.01
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on laser-induced shape changes of GNR solutions;32–34,57 
pulsed-laser irradiation of GNRs can lead to a rapid increase 
in electron temperature, causing an NP heating that can vary 
from a raise in temperature by only a few tens of degrees 
up to complete nanocrystal melting. The actual degree of 
NP heating is determined by several factors, including laser 
pump power, excitation wavelength, exposure duration, type, 
dimension, and surface coverage of the nanocrystals, medium 
in which the experiment is carried out, etc.57 In general, 
femtosecond laser pulses can induce a shape transformation 
of the nanocrystal, eg, from rod to sphere, while nanosecond 
laser pulses are more likely to cause fragmentation into 
smaller particles.57 However, the structural conversion of 
GNRs when exposed to intense laser pulses has already been 
studied in detail elsewhere34,57–59 and is beyond the scope of 
this paper.
In this study, an optimal laser configuration was deter-
mined for obtaining effective GNR-enhanced optoacoustic 
imaging and only a minimal, negligible transformation 
of GNRs into nanospheres (see Figure 5A). In fact, as 
expected, the morphological transformation rate of the 
GNRs into nanospheres resulted proportional to both laser 
fluence and exposure time. However, a limited number of 
gold nanospheres was observed by TEM imaging after 
irradiation at the mildest conditions used (laser fluence of 
30 mJ/cm2 for 20 seconds), consistent with a correspond-
ing absorption spectrum that was degraded by less than 
10% (see Figure 4). These results are also in qualitative 
agreement with those of a previous paper30 that reported 
a limited fragmentation and conversion to spherical shape 
for GNRs with an aspect ratio of 3.6 that underwent a 
20-second irradiation employing 800-nm laser pulses at a 
fluence of 30 mJ/cm2.
The identification of such a configuration could sig-
nif icantly facilitate the clinical employment of GNR 
contrast agents for optoacoustic imaging, allowing the 
fruitful exploitation of GNR advantages over other possible 
NPs (mainly in terms of a stronger optical absorption at 
resonance8,60 and of the possibility of being manufactured 
in a smaller size with respect to competitors with spheri-
cal symmetry32,60), combined with the retention of these 
properties for the entire duration of the diagnostic imaging 
procedure.
In order to verify further the latter concept in our 
experimental conditions, we also performed an additional 
20-second laser irradiation on GNR samples that had been 
already irradiated. Optoacoustic signals were acquired 
along both the longitudinal and the lateral direction 
through single-element US probes and were analyzed as 
previously described. The behavior of re-irradiated samples 
was almost identical to that shown during the first series 
of optoacoustic experiments, confirming that, at least 
regarding effectiveness in optoacoustic emission, the first 
20-second irradiation of GNRs did not appreciably affect 
their optical properties.
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Figure 9 Viability of heLa cells and MCF-7 cells determined by MTT test after 
24 hours’ (A), 48 hours’ (B), and 72 hours’ (C) exposure to gold nanorods (GNRs) 
in different concentrations (50 pM, 100 pM, and 200 pM). 
Notes: The dashed lines indicate a 70% cell viability; error bars represent standard 
deviations of three independent experiments. *Statistically significant difference with 
respect to the unexposed control (P , 0.01).
Abbreviation: MTT, (3-[4,5-dimethythiazol-2-yl]-2,5-diphenyl tetrazolium bromide).
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Effects of GNR concentration and sample 
volume on optoacoustic signal amplitude
Optoacoustic signal generation along a specific direction 
occurred proportional to both GNR concentration and sample 
volume (Figure 6A and B).
An explanation of the predominance of longitudinal 
optoacoustic amplitude over the lateral one can be sought in 
the sample area that is “seen” by each US probe (schematically 
illustrated by the sketches in Figure 6A and B). In fact, 
referring for instance to the case of Figure 6A and taking 
into account the parallelepiped-like shape of the solution 
housings (having a base of 7 × 7 mm), a 100-µL sample 
filled the cavity up to a level of about 2 mm, implying that the 
optoacoustic emitting volume had its base (49 mm2) facing 
the longitudinal probe (whose piezoelectric surface is about 
200 mm2) and only one of the lateral surfaces (about 14 mm2) 
facing the lateral probe, which is identical to the longitudinal 
one. Therefore, for each considered direction, we can define 
an “exposure factor” as the ratio between the optoacoustic 
emitting surface and the corresponding piezoelectric receiving 
surface (eg, in the mentioned case of a 100-µL sample, we 
obtain: “longitudinal exposure factor” = 49/200 = 0.245 and 
“lateral exposure factor” = 14/200 = 0.070).
In this context, taking into account the reasonable phan-
tom homogeneity, the isotropic emission of photoacoustic 
signals by the GNRs, and the fact that the longitudinal path 
of the photoacoustic signals is longer than the correspond-
ing lateral one, the sole attenuation phenomena would have 
caused a longitudinal signal weaker than the lateral one. 
Nevertheless, photoacoustic signal generation along a spe-
cific direction occurred proportional to the sample area in 
front of the corresponding US probe, and this phenomenon 
was shown to dominate acoustic attenuation, at least in our 
experimental conditions.
These considerations were quantitatively confirmed by 
the results reported in Table 3, showing the comparison 
between the ratio of longitudinal to lateral exposure factor 
and the ratio of longitudinal to lateral optoacoustic amplitude 
as a function of GNR sample volume. In fact, low volumes 
of GNR solution correspond to low filling levels in the solu-
tion housing, and consequently to small lateral areas emitting 
photoacoustic signals along the corresponding direction: this 
is the case of a 50-µL sample volume, which corresponds to 
a base area of 49 mm2 (longitudinal exposure factor = 0.245) 
and to a filling level of about 1 mm in the solution housing, 
giving a sample lateral area of about 7 mm2 (lateral exposure 
factor = 0.035). Therefore, the ratio of the exposure factors of 
the two transducers is 7, and this value is in good agreement 
with the optoacoustic amplitude ratio (Table 3). On the other 
hand, the progressive increment of sample volume caused 
a corresponding increment of the lateral exposure factor 
with respect to the constant longitudinal value: the ratio 
of optoacoustic amplitudes closely resembled the trend of 
exposure factor ratio (Table 3).
A further confirmation of these findings was obtained 
by irradiating GNR solutions contained in the phantom with 
cylindrical solution housings (6 mm in radius). Actually, 
cylindrical housings had a significantly wider base area with 
respect to squared housings (113 mm2, corresponding to a 
longitudinal exposure factor of 0.565) and the measured 
optoacoustic amplitudes reflected this difference, especially 
in the higher part of the tested GNR concentration range (see 
squares and empty circles in Figure 10).
However, the multiplication of each optoacoustic 
amplitude measured in cylindrical housings by a correction 
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Figure 10 Optoacoustic signal amplitude measured in the longitudinal direction 
as a function of gold nanorod (GNR) concentration for differently shaped solution 
housings. 
Notes: Cylindrical solution housings had a base area bigger than the square ones, 
and for this reason the measured optoacoustic amplitude was higher (uncorrected 
values). After multiplication for a correction factor taking into account the difference 
in base area, the trend of the optoacoustic amplitude measured in cylindrical solution 
housings became very similar to that measured in square housings (corrected values). 
Sample volume = 100 µL; error bars represent standard deviations.
Table 3 Comparison between the ratio of longitudinal (long) to 
lateral (lat) exposure factor and the ratio of longitudinal to lateral 
optoacoustic amplitude as a function of gold nanorod (GNR) 
sample volume 
GNR sample 
volume 
(μL)
Long exposure  
factor/ 
lat exposure factor
Long signal 
amplitude/ 
lat signal amplitude
50 7 6.09 ± 1.75
100 3.5 3.67 ± 0.36
200 1.75 1.58 ± 0.11
Note: GNR concentration = 100 pM.
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factor that took into account the exposure factor ratio 
(0.43 = 0.245/0.565) was sufficient to reach an optimal 
agreement between the trends of optoacoustic signal amplitude 
measured in the differently shaped solution housings (see 
full circles and squares in Figure 10). On the other hand, 
signals received by the lateral probe were very weak, and 
this phenomenon was attributed to the curvature of the lateral 
surface of cylindrical housings, which was likely to cause a 
significant refraction-related dispersion of the photoacoustic 
pulses propagating toward the lateral probe, thus not allowing 
any quantitative analysis on such signals.
Further comments are required regarding the behavior 
of optoacoustic signal amplitude as a function of GNR 
concentration. Actually, the employment of single-element 
US probes allowed us to divide the studied concentration 
range into two intervals: 50–200 pM (1.5 × 1010−1.2 × 1011 
GNRs/mL), in which the optoacoustic signal amplitude 
was almost linearly proportional to GNR concentration (see 
Figures 6, 7, and 10), and 0–50 pM, which showed a quite 
irregular trend, sometimes characterized by a sort of peak in 
correspondence of 25-pM concentration (this is particularly 
evident in Figure 7, in which RoE was plotted instead of 
optoacoustic amplitude). Taking into account that the lowest 
tested GNR concentrations were obtained by repeated 
dilutions from highly concentrated solutions, the observed 
behavior is probably attributable to some inefficiencies in 
the dilution procedure, in which the uncertainty of each 
dilution step is added to the previous one, leading to a final 
solution whose concentration level is affected by an elevated 
uncertainty. This observation finds confirmation in the 
relatively high standard deviation values typically observed 
in correspondence with 25-pM solutions.
On the other hand, a more regular behavior was found 
by analyzing the data acquired through the echographic 
transducer (see Table 1). In this case, transducer sensibility 
is probably a bit too low to fully appreciate all the 
fluctuations of samples labeled as “25 pM,” whose detected 
spot intensity is located almost at the same level as water 
maximum intensity. This produces an optoacoustic intensity 
trend that slowly increases with GNR concentration up to 
50 pM and then presents a marked jump passing from 50 to 
100 pM, followed by a final modest increment when GNR 
concentration reaches a value of 200 pM.
Potential application of GNRs for clinical 
imaging tasks
Recent papers have underlined the need for accurate 
experimental studies of the optoacoustic signals emitted 
by low concentrations of GNRs, possibly including the 
employment of conventional clinically available echographic 
devices, since the most interesting results reported in the 
literature10,15,24,26,28 have been obtained employing dedicated 
US systems with time-consuming imaging procedures. They 
have also underlined that photoacoustic molecular imaging 
using GNRs as CAs in combination with a commercial 
echographic platform would have direct clinical potential 
(eg, for very early detection and monitoring of inflammatory 
responses).24
The approach of the present study combined the adoption 
of a GNR concentration range (25–200 pM, corresponding 
to about 1.5 × 1010−1.2 × 1011 GNRs/mL) that is lower than 
those employed in the majority of recent papers15,24–26,28 with 
the experimental determination of the most suitable laser 
irradiation parameters and the employment of a conventional 
echographic machine, in order to assure several simultane-
ous benefits.
In fact, maximum optoacoustic effectiveness was achieved 
thanks to the full exploitation of the intrinsic GNR properties 
and to the optimized operative parameters. A facilitated 
transferability into clinical contexts was also guaranteed due 
to the demonstrated effectiveness of the method employing 
clinically available US devices. Safety was preserved as well 
by both modest laser fluence (30 mJ/cm2, corresponding to 
30% of the maximum permissible exposure for the skin at a 
laser in the NIR spectral range)54 and documented absence of 
appreciable GNR degradation during the imaging procedure. 
A high biocompatibility was further guaranteed by the PEG 
coating and by the demonstrated absence of cytotoxic effects 
on different human cell lines (Figure 9). Finally, it must 
be mentioned that there is enormous potential for future 
molecular imaging applications as a consequence of both 
the aforementioned advantageous small size of GNRs and 
their easy bioconjugation due to the strong binding affinity 
of gold with several antibodies and biomolecules.12
Moreover, the relationships between GNR concentration 
or volume and the characteristics of corresponding 
optoacoustic signals were quantitatively investigated using 
either single-element US probes (see Figures 6, 7, and 10 
and Table 3) and a conventional echographic transducer 
(Table 1, Table 2, and Figure 8), not only contributing to 
novel quantitative insights in optoacoustic signal features but 
also leading to the following important clinical implications: 
(1) the substantial isotropy of GNR photoacoustic emission 
was experimentally confirmed, implying that the relative 
placement of laser and US devices does not affect signal-
detection accuracy, and thus each time can be directly chosen 
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by the clinician on the basis of specific patient characteristics 
and diagnostic investigation requirements; (2) the amplitude 
of GNR-emitted optoacoustic signals showed clear 
proportionalities to both GNR concentration and sample 
volume, thus being particularly suited for monitoring 
the temporal evolution of a targeted pathological tissue (eg, 
the growth of a tumor mass or its reduction as a consequence 
of a therapeutic treatment, since the signal proportionality 
to GNR concentration can be useful for diagnosing a 
variation in the spatial density of targeted diseased cells, 
while the proportionality to GNR sample volume at constant 
concentration can help in monitoring possible volumetric 
changes of a targeted object).
In order to provide a more concrete idea of the 
exploitability of the detected signals on a conventional 
echographic device, sample echographic images of 
“optoacoustic spots” acquired during laser irradiation of 
different GNR solutions are reported in Figure 11.
Obviously, in order to actually extend our experimental 
results to clinical application, further in vivo verifications on 
animal models are necessary, especially to evaluate directly 
the possible effects of the GNR distribution in the target 
tissue. However, concerning this issue, reported studies15,31 
have documented feasible extensions to small animal models 
of previously in vitro–tested approaches for photoacoustic 
imaging, employing dedicated complex devices and time-
consuming procedures for target scanning and image 
reconstruction. Therefore, these data lead us to hypothesize 
that the in vivo translation of our simpler imaging protocol 
would also be feasible, and the adopted method is expected 
to maintain its effectiveness in the in vivo case as well, at 
least for superficial pathological targets.
A further exciting perspective in this research field is 
the possibility of carrying out both diagnostic investigation 
and subsequent therapeutic treatment through a single GNR 
injection, so introducing a newer example of a “theranostic” 
approach. This could be especially feasible for cancer 
pathologies, since GNR-assisted photothermal therapy has 
recently emerged as a viable method for selective killing 
of cancer cells and shows promise for effective clinical 
translation.31 In particular, it has been shown that the entity of 
the photothermal effect produced by GNRs following pulsed-
laser irradiation is proportional to laser-exposure duration,30 
which should last for some minutes in order to achieve 
clinically useful therapeutic results.30,31 In this context, this 
study has added a direct demonstration of GNR diagnostic 
effectiveness for photoacoustic imaging investigations 
performed with conventional echographic devices, employing 
very low GNR concentrations and a safe laser-energy level. 
Since a few seconds of laser irradiation are enough for the 
photoacoustic investigation of a specific clinical target, we 
can conclude that once the target has been reached by an 
injected dose of GNRs, the following steps will in principle 
be feasible: (1) acquisition of photoacoustic diagnostic images 
thanks to a first short laser irradiation, without causing any 
appreciable perturbation of GNR structure; and (2) if a tumor 
is detected, a second prolonged laser irradiation could be used 
for selective photothermal ablation, the effectiveness of which 
could in turn be real-time monitored through simultaneous 
acquisition of photoacoustic images, also in order to tailor 
the most suitable duration of laser irradiation.
Conclusion
The diagnostic performance of GNRs for optoacoustic 
imaging was experimentally optimized in a novel tissue-
mimicking phantom, employing both single-element US 
probes and a conventional clinically available echograph.
The most suitable values of laser parameters (30 mJ/cm2 
fluence for 20 seconds of exposure) were determined in order 
to assure optoacoustic effectiveness, NP stability and safety 
of the imaging procedure in the presence of PEG-coated 
GNRs. The effects of GNR concentration and sample volume 
on GNR-emitted optoacoustic signals were separately 
investigated in very low ranges, showing the potential for 
Figure 11 (A–F) Sample echographic images of “optoacoustic spots” detected 
during laser irradiation at 30 mJ/cm2 of gold nanorod (GNR) solutions of 
variable volume and concentration. (A) GNR concentration = 25 pM, sample 
volume = 100 µL; (B) GNR concentration = 50 pM, sample volume = 100 µL; (C) GNR 
concentration = 200 pM, sample volume = 100 µL; (D) GNR concentration = 100 pM, 
sample volume = 50 µL; (E) GNR concentration = 100 pM, sample volume = 100 µL; 
(F) GNR concentration = 100 pM, sample volume = 200 µL.
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the development of novel molecular imaging protocols and 
theranostic approaches.
An experimental confirmation for the isotropic emission 
assumption of GNR photoacoustic signals was also provided, 
introducing the definition of an “exposure factor” that takes 
into account the geometrical characteristics of both the GNR 
target volume and the receiving probe. This will enable a 
constraint-free relative positioning of laser and US devices 
during clinical diagnostic investigations, so extending the 
variety of accessible targets.
Clinical translation of reported results will actually be 
facilitated by the demonstrated detectability of “optoacoustic 
spots” through a conventional echographic device and by 
the absence of GNR-related cytotoxic effects, documented 
on two different human cell lines. Based on our obtained 
results, an “optimal” GNR concentration can be indicated in 
a 100-pM solution (corresponding to 6 × 1010 GNRs/mL).
Finally, this work presented a new experimental setup for 
the quantitative assessment of all the main parameters that 
influence the performance of CAs for optoacoustic imaging 
(laser settings, relative placement of laser source, and US 
transducer, concentration, and volume of CA solution, shape 
of CA volume, US probe features), therefore introducing a 
novel approach for a global performance evaluation of pos-
sible newer CAs for optoacoustic imaging.
Future studies will involve the determination of the 
most suitable parameter configuration for experimental 
investigation of innovative diagnostic and therapeutic 
paradigms on specific animal models, with the final goal of 
exploiting the enormous potential of the illustrated approach 
for future applications of optoacoustic molecular imaging 
and personalized medicine.
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